Pathogenesis, Diagnosis, and Treatment of Cardiomyopathy: Special Focus on Infiltrative Cardiomyopathy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 61
Special Issue Editor
2. Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth, Birmingham B15 2GW, UK
Interests: Inherited cardio-metabolic condition; cardiomyopathies & cardiac imaging
Special Issue Information
Dear Colleagues,
Infiltrative cardiomyopathies are a challenging group of conditions that present with diverse clinical manifestations and are associated with adverse prognoses. The etiopathogenesis is heterogeneous, including genetic abnormalities, cardiac myocyte injury, and infiltrative processes involving the myocardium. These eventually lead to abnormal deposition of specific substances in the myocardium. The extent of cardiac involvement ranges from left ventricular hypertrophy/dilatation/impairment to conduction system involvement, resulting in life-threatening arrhythmias. They can present in any of the three phenotypes commonly seen in cardiomyopathy, i.e., dilated, hypertrophic, and restrictive cardiomyopathies.
They are the least common form of heart muscle conditions. The rarity of some of these conditions requires a high degree of clinical suspicion to make a clinical diagnosis. Electrocardiography and echocardiography are helpful screening tools, but more advanced and complex investigations are needed, including cardiac magnetic resonance, nuclear imaging, and endomyocardial biopsy. Treatment mainly depends on the underlying etiology, making early detection key to good outcomes.
The more common secondary forms of infiltrative cardiomyopathies include amyloidosis, sarcoidosis, hemochromatosis, and storage disorders like Fabry disease. Renewed focus on some of these conditions in recent years has led to innovative treatment strategies and approval of new treatments like disease-modifying transthyretin kinetic stabilizer for treating transthyretin (ATTR) amyloidosis.
It is my pleasure to invite you to submit your work on the pathogenesis, diagnosis, and treatment of different types of cardiomyopathy, with a special focus on the diverse etiopathogenesis, challenges associated with diagnosis, prognostication, and upcoming management strategies for infiltrative cardiomyopathies.
Dr. Shanat Baig
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infiltrative cardiomyopathy
- amyloidosis
- sarcoidosis
- hemochromatosis
- Fabry disease
- glycogen storage disorders
- lysosomal storage disorders
- Danon disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
